Regulation of estrogen receptor α and progesterone receptor (isoform A and B) expression in cultured human endometrial cells

Summary:

The effects of RU 486 together with estradiol and progesterone on estrogen receptor α and progesterone receptor (isoforms A and B) expression were studied in human endometrial long term cultures at the mRNA and protein level. We asked whether ligand induced receptor regulation, found in mammals in vivo, is also found in human cultured endometrial cells with special regard to the progesterone isoforms A and B. Endometrial cultures were maintained for 27 days. Media were supplemented with progesterone and/or estradiol alone or in combination with RU 486. Receptor expression (estrogen receptor α and progesterone receptor isoform A and B) was examined at the mRNA level by RT-PCR and at the protein level by western blot analysis. All receptor types examined were expressed in our culture model. Estradiol led to a general increase of receptor expression whereas treatment with estradiol in combination with progesterone down regulated receptor expression. The receptor down regulation was not found when RU 486 was additionally supplemented into the medium. Activation or inhibition of expression due to these treatments was similar for both PR isoforms. Our results (1) show that in our culture system estradiol induced up regulation of estrogen receptor and progesterone receptor A and B and suggest that the estrogen induced up regulation is prevented by progesterone (2) a clear cut antigestagenic effect of RU 486 and (3) suggest that both progesterone isoforms are analogously regulated in our culture model. We conclude that human endometrial cell cultures are suitable for the study of the dynamics of steroid receptor expression.

Key words:

Human endometrial cell culture - estrogen receptor - progesterone receptor - steroids - RU 486

References

• 1 Amso N N, Crow J, Shaw R W. Comparative immunohistochemical study of oestrogen and progesterone receptors in the fallopian tube and uterus at different stages of the menstrual cycle and the menopause.  Hum Reprod. 9 1027-1037 1994; 
• 2 Beyer C. Estrogen and the developing mammalina brain.  Anat Embryol. 199 379-390 1999; 
• 3 Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.  Anal Biochem. 72 248-254 1976; 
• 4 Chen G, Huang J R, Mazella J, Tseng L. Long-term effects of progestin and RU 486 on prolactin production and synthesis in human endometrial stromal cells.  Hum Reprod. 4 355-358 1989; 
• 5 Chen D, Klebe R J. Controls for validation of relative reverse transcription-polymerase chain reaction assays.  PCR Methods Appl. 3 127-129 1993; 
• 6 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.  Anal Biochem. 162 156-159 1987; 
• 7 Dockery P, Ismail R M, Li T C, Warren M A, Cooke I D. The effect of a single dose of mifepristone (RU486) on the fine structure of the human endometrium during the early luteal phase.  Hum Reprod. 12 1778-1784 1997; 
• 8 Gemzell Danielsson K, Swahn M L, Westlund P, Johannisson E, Seppälä M, Bygdeman M. Effect of low daily doses of mifepristone on ovarian function and endometrial development.  Hum Reprod. 12 124-131 1997; 
• 9 Gemzell Danielsson K, Westlund P, Johannisson E, Swahn M L, Bygdeman M, Seppälä M. Effect of low weekly doses of mifepristone on ovarian function and endometrial development.  Hum Reprod. 11 256-264 1996; 
• 10 Greb R R, Heikinheimo O, Williams R F, Hodgen G D, Goodman A L. Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo.  Hum Reprod. 12 1280-1292 1997; 
• 11 Green S, Philippe W, Kumar V, Krust A, Bornert J-M, Argos P, Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A.  Nature. 320 134-139 1986; 
• 12 Horwitz K B. The antiprogestin RU 38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T-47Dco human breast cancer cells.  Endocrinology. 116 2236-2245 1985; 
• 13 Ing N H, Ott T L. Estradiol up-regulates estrogen receptor-alpha messenger ribonuleic acid in sheep endometrium by increasing its stability.  Biol Reprod. 60 134-139 1999; 
• 14 Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.  EMBO J. 9 1603-1614 1990; 
• 15 Kiesel L, Mappes M. Regulation of endometrial differentiation by synthetic steroids in vitro.  Ann N Y Acad Sci. 734 237-244 1994; 
• 16 Klein-Hitpass L, Cato A C, Henderson D, Ryffel G U. Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T-47D cells.  Nucleic Acids Res. 19 1227-1234 1991; 
• 17 Lau M T, Witjaksono J, Affandi B, Rogers P AW. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.  Hum Reprod. 11 2629-2634 1996; 
• 18 Mäentausta O, Svalander P, Gemzell Danielsson K, Bygdeman M, Vihko R. The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study.  J Clin Endocrinol Metab. 77 913-918 1993; 
• 19 Mangal R K, Wiehle R D, Poindexter A , Weigel N L. Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle.  J Steroid Biochem Mol Biol. 63 195-202 1997; 
• 20 Marions L, Danielsson K G, Swahn M L, Bygdeman M. Contracepitive efficacy of low doses of mifepristone.  Fertil Steril. 70 813-816 1998; 
• 21 McKenna N J, Lanz R B, O'Malley B W. Nuclear receptor coregulators: cellular and molecular biology.  Endocr Rev. 20 321-344 1999; 
• 22 Misao R, Fujimoto J, Nakanishi Y, Tamaya T. Expression of estrogen and progesterone receptors and their mRNAs in ovarian endometriosis.  Gynecol Endocrinol. 10 303-310 1996; 
• 23 Montano M M, Ekena K, Delage-Mourroux R, Chang W, Martini P, Katzenellenbogen B S. An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens.  Proc Natl Acad Sci USA. 8 6947-6952 1999; 
• 24 Philibert D, Deratedt R, Tournemine C. RU 38486 - a potent antiprogesterone.  J Steroid Biochem. 17 Abstr. no. 204 1982; 
• 25 Prange-Kiel J, Rune G M, Wallwiener D, Kiesel L. Inhibition of proliferation and differentiation by RU 486 in human endometrial stromal and epithelial cells in vitro.  Exp Clin Endocrinol Diabetes. 108 275-281 2000; 
• 26 Schwartz L B, Krey L, Demopoulos R, Goldstein S R, Nachtigall L E, Mittal K. Alterations in steroid hormone receptors in the tamoxifen-treated endometrium.  Am J Obstet Gynecol. 176 129-137 1997; 
• 27 Shoupe D, Mishell D R, Page M A, Madkour H, Spitz I M, Lobo R A. Effects of the antiprogesterone RU 486 in normal woman. II. Administration in the late follicular phase.  Am J Obstet Gynecol. 157 1421-1426 1987; 
• 28 Slayden O D, Brenner R M. RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mullatta).  J Clin Endocrinol Metab. 78 440-448 1994; 
• 29 Swahn M L, Bygdeman M, Cekan S, Xing S, Masironi B, Johannisson E. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.  Hum Reprod. 5 402-408 1990; 
• 30 Swahn M L, Johannisson E, Daniore V, de la Torre B, Bygdeman M. The effect of RU 486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.  Hum Reprod. 3 915-921 1988; 
• 31 Tseng L, Gao J G, Chen R, Zhu H H, Mazella J, Powell D R. Effect of progestin, antiprogestin, and relaxin on the accumulation of prolactin and insulin-like Growth Factor-Binding Protein-1 messenger ribonucleic acid in human endometrial stromal cells.  Biol Reprod. 47 441-450 1992; 
• 32 Taylor A H, Al-Azzawi F. Immunolocalisation of oestrogen receptor beta in human tissues.  J Mol Endocrinol. 24 145-155 2000; 
• 33 Viville B, Charnock-Jones D S, Sharkey A M, Wetzka B, Smith S K. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leimyomata and adjacent myometrium.  Hum Reprod. 12 815-822 1997; 
• 34 Wu W X, Owiny J, Zhang Q, Ma X H, Nathanielsz P W. Regulation of the estrogen receptor and its messenger ribonucleic acid in the ovariectomized sheep myometrium and endometrium: the role of estradiol and progesterone.  Biol Reprod. 55 762-768 1996; 
• 35 Xiao C W, Goff A K. Hormonal regulation of estrogen and progesterone receptors in cultured bovine endometrial cells.  J Reprod Fertil. 115 101-109 1999; 
• 36 Zeimet A G, Müller-Holzner E, Marth C, Daxenbichler G. Immunocytochemical versus biochemical receptor determination in normal and tumorous tissues of the female reproductive tract and the breast.  J Steroid Biochem Mol Biol. 49 365-372 1994;